Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis

Authors


  • Funding sources: none.

  • Conflicts of interest: R.B.W. has acted as a consultant, speaker and/or had funding support for research from Abbott, Janssen, Pfizer and MSD, all of whom manufacture biological agents. C.E.M.G. has acted as a speaker and consultant for Abbott, Pfizer, Leo, Janssen, Novartis and MSD.

No abstract is available for this article.

Ancillary